Ameritas Advisory Services, LLC Biocryst Pharmaceuticals Inc Transaction History
Ameritas Advisory Services, LLC
- $1.85 Billion
- Q2 2025
A detailed history of Ameritas Advisory Services, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 1,564 shares of BCRX stock, worth $13,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,564Holding current value
$13,059% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
309Shares Held
191MCall Options Held
729KPut Options Held
492K-
Vanguard Group Inc Valley Forge, PA20.5MShares$172 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$167 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$74.6 Million5.64% of portfolio
-
State Street Corp Boston, MA8.51MShares$71 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$47.7 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.55B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...